We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.86B
AUM Growth
+$129M
Cap. Flow
-$222M
Cap. Flow %
-5.74%
Top 10 Hldgs %
5.3%
Holding
1,514
New
109
Increased
323
Reduced
286
Closed
149

Top Buys

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$10.9M
2
SASR
Sandy Spring Bancorp Inc
SASR
+$8.99M
3
T icon
AT&T
T
+$8.64M
4
RRR icon
Red Rock Resorts
RRR
+$8.46M
5
MCY icon
Mercury Insurance
MCY
+$8.11M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$19.9M
2
CRK icon
Comstock Resources
CRK
+$15.5M
3
SM icon
SM Energy
SM
+$14.3M
4
AR icon
Antero Resources
AR
+$14.2M
5
MCK icon
McKesson
MCK
+$12.9M

Sector Composition

Rank Sector Weight
1 Financials 28.28%
2 Consumer Discretionary 11.1%
3 Industrials 10.71%
4 Energy 9.76%
5 Technology 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXYN
1101
DELISTED
Dixie Group Inc
DXYN
$186K ﹤0.01%
232,200
+22,000
+10% +$21.8K
LUCD icon
1102
Lucid Diagnostics
LUCD
$184M
$184K ﹤0.01%
135,000
-50,000
-27% -$90K
PLX icon
1103
Protalix BioTherapeutics
PLX
$198M
$183K ﹤0.01%
133,790
– –
SBFM
1104
Sunshine Biopharma
SBFM
$2.93M
$183K ﹤0.01%
14
– –
VIRX
1105
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$183K ﹤0.01%
125,000
+30,000
+32% +$87.6K
MXC icon
1106
Mexco Energy
MXC
$19M
$182K ﹤0.01%
14,568
– –
TCRR
1107
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$182K ﹤0.01%
181,810
+50,000
+38% +$67.4K
BCAB icon
1108
BioAtla
BCAB
$5.74M
$182K ﹤0.01%
440
– –
OPTN
1109
DELISTED
OptiNose
OPTN
$180K ﹤0.01%
6,493
– –
LFMD icon
1110
LifeMD
LFMD
$172M
$180K ﹤0.01%
92,800
+35,000
+61% +$78.5K
ICD
1111
DELISTED
Independence Contract Drilling, Inc.
ICD
$180K ﹤0.01%
55,000
– –
KLR
1112
DELISTED
Kaleyra, Inc.
KLR
$178K ﹤0.01%
67,400
– –
BLFY
1113
DELISTED
Blue Foundry Bancorp
BLFY
$177K ﹤0.01%
13,800
– –
JNCE
1114
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$176K ﹤0.01%
159,000
-5,000
-3% -$7.12K
RGS icon
1115
Regis Corp
RGS
$70.2M
$176K ﹤0.01%
+7,225
New +$172K
SYBX
1116
DELISTED
Synlogic
SYBX
$175K ﹤0.01%
15,333
– –
BDSX icon
1117
Biodesix
BDSX
$248M
$173K ﹤0.01%
3,750
-1,250
-25% -$34K
LUMO
1118
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$172K ﹤0.01%
47,643
– –
TARA icon
1119
Protara Therapeutics
TARA
$232M
$172K ﹤0.01%
64,000
– –
SRTS icon
1120
Sensus Healthcare
SRTS
$50.5M
$171K ﹤0.01%
23,100
– –
INAB icon
1121
IN8bio
INAB
$9.64M
$171K ﹤0.01%
2,467
– –
HYFM icon
1122
Hydrofarm Holdings
HYFM
$7.62M
$171K ﹤0.01%
11,000
-4,000
-27% -$91.4K
SYPR icon
1123
Sypris Solutions
SYPR
$46.7M
$170K ﹤0.01%
84,404
– –
EVLO
1124
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$170K ﹤0.01%
5,265
– –
IMRX icon
1125
Immuneering
IMRX
$292M
$170K ﹤0.01%
34,949
– –
43 44
45
46 47

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Bridgeway Capital Management held 1,514 positions worth $3.86B, up 3.4% from $3.73B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Bridgeway Capital Management withdrew a net $222M in Q4 2022, closing 149 positions and reducing 286 holdings. Its most notable exit was Comstock Resources, an estimated $15.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in eBay worth $10.9M.

  • Bridgeway Capital Management's largest Q4 2022 buy was eBay: 263,700 shares worth $10.9M.
  • Bridgeway Capital Management added most to AT&T in Q4 2022, an estimated $8.64M increase.
  • Bridgeway Capital Management's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $19.9M.
  • Bridgeway Capital Management fully exited Comstock Resources in Q4 2022, selling an estimated $15.5M.
  • Bridgeway Capital Management's ten largest holdings make up 5.3% of its $3.86B portfolio in Q4 2022.
  • Bridgeway Capital Management opened 109 new positions and closed 149 in Q4 2022.
  • Bridgeway Capital Management's portfolio value rose 3.4% quarter-over-quarter to $3.86B.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.